Autolus Therapeutics (AUTL) Reports In-Line Q1 EPS

Autolus Therapeutics (NASDAQ: AUTL) reported Q1 EPS of ($0.26), in-line with the analyst estimate of ($0.26).

For earnings history and earnings-related data on Autolus Therapeutics (AUTL) click here.

You May Also Be Interested In

• NPR retracts story about Justice Alito retiring from Supreme Court
• FDA allows ZYN to sell pouches on health benefits - Axios
• Keysight and WIN Semiconductors launch joint GaN MMIC design workflow